4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000008
CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $122.25 ($611,273)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-06 | Sale : show line 1 in the form 10b5-1 | −3,124 | $121.67 | $380,097 | 44,057 | D |
| 2026-07-06 | Sale : show line 2 in the form 10b5-1 | −1,048 | $122.43 | $128,307 | 43,009 | D |
| 2026-07-06 | Sale : show line 3 in the form 10b5-1 | −528 | $123.84 | $65,388 | 42,481 | D |
| 2026-07-06 | Sale : show line 4 in the form 10b5-1 | −300 | $124.94 | $37,482 | 42,181 | D |
| Open-market sales · 5,000 sh · avg $122.25 · $611,273 | ||||||
Loading xslF345X06/form4-07082026_090727.xml…